Ardelyx Inc.

235 articles about Ardelyx Inc.

• Bay Area's Ardelyx Wants to Raise $110 Million in a Private Placement

  7/15/2016

• Ardelyx Reports Progress Of Development Programs

  6/22/2016

• Ardelyx Appoints Robert Bazemore To Its Board Of Directors

  6/7/2016

• BIO2016: Ardelyx To Present At 2016 BIO International Convention

  6/3/2016

• Ardelyx Reports First Quarter 2016 Financial Results

  5/10/2016

• Ardelyx To Report First Quarter 2016 Financial Results On May 9, 2016

  5/3/2016

• Ardelyx Reports Fourth Quarter and Full-Year 2015 Financial Results

  3/4/2016

• Ardelyx To Report Fourth Quarter And Full Year 2015 Financial Results On March 4th, 2016

  2/25/2016

• Ardelyx To Present At The 2016 Leerink Partners Global Healthcare Conference

  2/3/2016

• Ardelyx Announces Closing Of Public Offering Including Exercise Of Underwriters' Right To Purchase Additional Shares

  1/14/2016

• Ardelyx Announces Pricing Of Public Offering Of Common Stock

  1/8/2016

• Ardelyx Announces Proposed Public Offering Of Common Stock

  1/7/2016

• Ardelyx Reports Positive Clinical Results Of RDX022 For The Treatment Of Hyperkalemia

  1/5/2016

• Ardelyx Strengthens Executive Leadership Team With The Appointment Of Paul Korner, MD, MBA, As Executive Vice President And Chief Medical Officer

  1/4/2016

• Ardelyx Reports Third Quarter 2015 Financial Results

  11/12/2015

• Ardelyx To Report Third Quarter 2015 Financial Results On November 12, 2015

  10/30/2015

• Ardelyx Announces Upcoming Presentations For Tenapanor At The American Society of Nephrology's Kidney Week Meeting 2015

  10/28/2015

• Ardelyx Appoints William Bertrand, Jr. To Its Board Of Directors

  10/27/2015

• Ardelyx To Present Phase 2 Data For Tenapanor In IBS-C Patients At The 2015 American College of Gastroenterology Annual Meeting

  10/9/2015

• Sanofi Terminates a $200 Million NaP2b Development Deal With Ardelyx

  9/3/2015